Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
1.188 AUD | -0.21% | -1.86% | -6.50% |
18.12. | ASX Small-Cap-Aktien zum Beobachten | MT |
27.11. | Monash IVF Group Limited - Shareholder/Analyst Call |
Voraussichtliche Gewinn- und Verlustrechnung: Monash IVF Group Limited
Steuerjahr: Juni | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Umsatz 1 | 145.4 | 183.6 | 192.3 | 213.6 | 255 | 277.7 | 293.9 | 309 |
Veränderung | - | 26.26% | 4.73% | 11.07% | 19.37% | 8.9% | 5.84% | 5.14% |
EBITDA 1 | 34.8 | 47.75 | 48.14 | 53.43 | 62.81 | 69.16 | 74.17 | 78.44 |
Veränderung | - | 37.22% | 0.83% | 10.98% | 17.55% | 10.12% | 7.24% | 5.77% |
Betriebsergebnis (EBIT) 1 | 24.45 | 34.86 | 33.36 | 38.09 | 44.23 | 49.09 | 53.49 | 57 |
Veränderung | - | 42.58% | -4.31% | 14.18% | 16.12% | 10.99% | 8.97% | 6.56% |
Gezahlte Zinsen 1 | -5.7 | -2.451 | -2.147 | -3.279 | -5.312 | -6.4 | -6.975 | -6.575 |
Gewinn vor Steuern (EBT) 1 | 16.13 | - | 26.22 | 29.84 | - | 42.14 | 45.54 | 49.64 |
Veränderung | - | -100% | - | 13.79% | -100% | - | 8.07% | 9% |
Nettoergebnis 1 | 11.73 | 25.15 | 18.41 | 21.84 | -5.949 | 30.87 | 32.93 | 35.48 |
Veränderung | - | 114.46% | -26.81% | 18.65% | - | - | 6.67% | 7.75% |
Datum der Veröffentlichung | 23.08.20 | 23.08.21 | 25.08.22 | 21.08.23 | 21.08.24 | - | - | - |
Vorläufige Bilanz: Monash IVF Group Limited
Steuerjahr: Juni | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Nettoverschuldung 1 | 4.2 | -7.1 | 2.1 | 31 | 48.7 | 79.4 | 62.4 | 60.8 |
Veränderung | - | -269.05% | -70.42% | 1’376.19% | 57.1% | 63.15% | -21.41% | -2.56% |
Datum der Veröffentlichung | 23.08.20 | 23.08.21 | 25.08.22 | 21.08.23 | 21.08.24 | - | - | - |
Prognostizierter Cashflow: Monash IVF Group Limited
Steuerjahr: Juni | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
CAPEX Investitionsaufwand 1 | 7.5 | 11.29 | 11.76 | 27.79 | 21.67 | 16.74 | 17.42 | 18.11 |
Veränderung | - | 50.49% | 4.22% | 136.24% | -22.01% | -22.75% | 4.06% | 3.94% |
Free Cashflow (FCF) 1 | 23.6 | - | 16.7 | - | 30.85 | 39 | 44 | 47.17 |
Veränderung | - | - | - | - | - | 26.43% | 12.82% | 7.2% |
Datum der Veröffentlichung | 23.08.20 | 23.08.21 | 25.08.22 | 21.08.23 | 21.08.24 | - | - | - |
Voraussichtliche Finanzkennzahlen: Monash IVF Group Limited
Steuerjahr: Juni | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Rentabilität | ||||||||
EBITDA-Marge (%) | 23.93% | 26.01% | 25.04% | 25.02% | 24.63% | 24.91% | 25.24% | 25.39% |
EBIT-Marge (%) | 16.81% | 18.99% | 17.35% | 17.83% | 17.35% | 17.68% | 18.2% | 18.45% |
EBT-Marge (%) | 11.09% | - | 13.64% | 13.97% | - | 15.18% | 15.5% | 16.07% |
Nettogewinn (%) | 8.06% | 13.7% | 9.57% | 10.22% | -2.33% | 11.12% | 11.21% | 11.48% |
FCF-Marge N (%) | 16.23% | - | 8.68% | - | 12.1% | 14.05% | 14.97% | 15.27% |
FCF / Nettogewinn (%) | 201.26% | - | 90.73% | - | -518.52% | 126.33% | 133.62% | 132.94% |
Rentabilität | ||||||||
ROA | 4.1% | 7.18% | 5.03% | 5.44% | 6.42% | 7.06% | 8.36% | 8.55% |
ROE | 5.7% | 8.6% | 8.2% | 9.3% | 10.7% | 12.51% | 13% | 13.42% |
Finanzielle Gesundheit | ||||||||
Verschuldungsgrad (Verbindlichkeiten/EBITDA) | 0.12x | - | 0.04x | 0.58x | 0.77x | 1.15x | 0.84x | 0.78x |
Verschuldung / Free Cashflow | 0.18x | - | 0.13x | - | 1.58x | 2.04x | 1.42x | 1.29x |
Kapitalintensität | ||||||||
CAPEX / Umsatz (%) | 5.16% | 6.15% | 6.12% | 13.01% | 8.5% | 6.03% | 5.93% | 5.86% |
CAPEX / EBITDA (%) | 21.55% | 23.64% | 24.43% | 52.01% | 34.51% | 24.21% | 23.49% | 23.08% |
CAPEX / FCF (%) | 31.78% | - | 70.44% | - | 70.26% | 42.92% | 39.59% | 38.39% |
Elemente pro Aktie | ||||||||
Cashflow pro Aktie 1 | 0.1204 | 0.1127 | 0.0814 | 0.0997 | 0.1348 | 0.0346 | 0.1384 | 0.1453 |
Veränderung | - | -6.4% | -27.77% | 22.48% | 35.2% | -74.37% | 300.46% | 5.02% |
Dividende pro Aktie 1 | 0.021 | 0.042 | 0.044 | 0.044 | 0.05 | 0.052 | 0.0585 | 0.0638 |
Veränderung | - | 100% | 4.76% | 0% | 13.64% | 3.92% | 12.59% | 8.99% |
Buchwert je Aktie 1 | 0.9768 | 0.6844 | 0.6876 | 0.7012 | 0.6208 | 0.6581 | 0.6855 | 0.7103 |
Veränderung | - | -29.93% | 0.46% | 1.98% | -11.46% | 6% | 4.16% | 3.61% |
Gewinn pro Aktie 1 | 0.045 | - | 0.047 | 0.056 | -0.017 | 0.0768 | 0.0842 | 0.0906 |
Veränderung | - | - | - | 19.15% | -130.36% | -551.94% | 9.64% | 7.56% |
Anz. der Aktien (in Tausend) | 389’635 | 389’635 | 389’635 | 389’635 | 389’635 | 389’635 | 389’635 | 389’635 |
Datum der Veröffentlichung | 23.08.20 | 23.08.21 | 25.08.22 | 21.08.23 | 21.08.24 | - | - | - |
2025 * | 2026 * | |
---|---|---|
KGV | 15.5x | 14.1x |
KBV | 1.81x | 1.74x |
EV / Sales | 1.96x | 1.79x |
Rendite | 4.37% | 4.92% |
Gewinn pro Aktie & Dividende
Historische Entwicklung KGV
Entwicklung der Dividendenrendite
Quartalsumsätze - Abweichungsrate
- Börse
- Aktien
- A116LZ Aktie
- Finanzen Monash IVF Group Limited
MarketScreener is also available in this country: United States.
Switch edition